MEDIUM confidence: 100% data completeness, but the composite (58) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.8B— | $8.4B+6.9% | $9.7B+15.7% | $10.4B+7.3% | $11.2B+7.5% |
| EPS (dil.) | $2.96— | $3.46+16.9% | $4.54+31.2% | $6.04+33.0% | $6.83+13.1% |
| Free Cash Flow | $943M— | $889M-5.7% | $1.0B+14.2% | $1.6B+60.3% | $1.5B-7.9% |
| Gross Margin | 30.3% | 30.4%+0.1pp | 30.4%+0.0pp | 32.4%+2.0pp | 31.5%-0.9pp |
| Operating Margin | 11.2% | 12.1%+0.9pp | 13.1%+1.0pp | 15.5%+2.4pp | 16.7%+1.2pp |
| Net Margin | 7.1% | 7.6%+0.4pp | 8.4%+0.9pp | 10.2%+1.7pp | 10.5%+0.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $341 (last qtr, 4 analysts) → $341 (last mo, 4) (+0.0%).
Buy-rated share 82% → 83% over ~3 months (+2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.60 | $2.76 | +6.2% |
| Apr 2026 | $2.51 | $2.71 | +8.0% |
| Feb 2026 | $2.08 | $2.10 | +1.0% |
| Oct 2025 | $2.28 | $2.32 | +1.8% |
| Jul 2025 | $2.17 | $1.96 | -9.7% |
| Apr 2025 | $2.03 | $2.28 | +12.3% |
| Feb 2025 | $1.74 | $1.68 | -3.4% |
| Oct 2024 | $1.90 | $2.00 | +5.3% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$24.7M over 180 days (0 open-market buys, 62 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 8.7%/yr (revenue basis).
Base free cash flow $1.4B (avg FY2023–FY2025; latest year $1.5B) · equity value $49.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 58 for WAB indicates a neutral outlook, with the short-term score of 61 being slightly more favorable than the long-term score of 55. WAB's score is driven up by its strong momentum, with a 12-month return of 52.4% and a bullish 50-day versus 200-day moving average. However, the stock's value score is held back by its premium valuation, including a P/E of 39.5 and EV/EBITDA of 22.9, while its growth and profitability scores are also middling due to mixed results in revenue and earnings growth.